Respiratory
Respiratory diseases affect the lungs and airways, leading to difficulty breathing and reduced oxygen exchange. They can be acute (short-term, like flu or respiratory distress syndrome) or chronic (long-term, such as asthma or COPD).
These conditions are a major global health burden, responsible for millions of deaths each year, mainly due to smoking, pollution, infections, and aging populations.
Products
- Broncositol
- Broncositol Vial
Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease (COPD)
Chronic obstructive pulmonary disease (COPD) affects around 10% of adults aged 30 to 79 worldwide, corresponding to approximately 392 million people.
It is a progressive condition characterized by persistent airflow limitation and breathing difficulties resulting from chronic inflammation of the airways.
Beyond its respiratory impact, COPD significantly reduces overall life expectancy—by an average of 6 to 9 years—and poses a major global health challenge due to its high prevalence, chronic progression, and substantial burden on patients’ quality of life.
Asthma
Asthma
Asthma affects approximately 262 million people worldwide, representing around 3–4% of the global population.
It is a chronic inflammatory disease marked by airway hyperreactivity, which causes symptoms such as wheezing, coughing, and shortness of breath.
When properly managed, individuals with asthma can maintain a normal life expectancy, but severe or uncontrolled cases can be life-threatening, contributing to an estimated 461,000 deaths each year.
Respiratory Distress Syndrome (ARDS)
Respiratory Distress Syndrome (ARDS)
Acute respiratory distress syndrome (ARDS) affects an estimated over 3 million people worldwide each year.
It is a serious condition often triggered by infection, inflammation, or severe injury, leading to impaired oxygen exchange and respiratory failure.
Despite advances in critical care, hospital mortality remains high—around 35–46%, and many survivors experience long-term lung damage and reduced respiratory function, making ARDS a major cause of morbidity and mortality globally.
Bronchiectasis
Bronchiectasis
Flu
Flu
Influenza affects an estimated 1 billion people worldwide each year, with 3 to 5 million cases classified as severe.
It is a viral infection of the respiratory tract that causes inflammation, coughing, and breathing difficulties, particularly in fragile or high-risk individuals such as the elderly or those with chronic illnesses.
While most people fully recover, influenza can be fatal in vulnerable populations, accounting for approximately 290,000 to 650,000 deaths annually across the globe.
Products
- Inofolic HP
- Inofolic Combi HP
- Inofolic phD
- Inofolic Plus
- Inofolic Luteal
- Xyminal
- Delphys
- Delphys Plus
- Aleract
- Aleract HA
- Zyxelle
- Zyxelle Plus
- Eumastós
- Eumastós Gel
- Zoyphen NRT
- Santes
- Ialos
- Pervistop
- Pervistop Foam
- Biguanelle Solution
- Biguanelle Gel
- Biguanelle Ovules
- Emogut
- Emogut Forte
- Synostea
